In vivo curcumin administration interfered with the development of distinctive characteristics associated with the NAFLD/nonalcoholic steatohepatitis phenotype, such as obesity and glucose intolerance, and improved histological alterations, including fibrosis and the intrahepatic accumulation of CD4+ cells. The gene discussed is CD4; the disease is metabolic dysfunction-associated steatotic liver disease.